英文名稱 |
中文名稱 |
CAS號 |
操作 |
4-[2-(1H-pyrrolo[2,3-b]pyridin-1-yl)ethyl]morpholine |
|
918531-87-0 |
詳細(xì)
|
Drostanolone Propionate |
|
521-12-0 |
詳細(xì)
|
H-Asp-Asp-Asp-Asp-OH |
|
145224-95-9 |
詳細(xì)
|
Mca-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (669-674)-Lys(Dnp) |
|
|
詳細(xì)
|
Arg-Glu(EDANS)-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (668-675)-Lys(DABCYL)-Arg |
|
310427-94-2 |
詳細(xì)
|
AF-1 |
|
130092-56-7 |
詳細(xì)
|
Insulin Receptor (689-702) |
|
|
詳細(xì)
|
2,3,7,8,12,13,17,18-Octaethyl-21H,23H-porphine ruthenium(II) carbonyl |
|
41636-35-5 |
詳細(xì)
|
H-Phe-Leu-Arg-Phe-NH2 |
|
80690-77-3 |
詳細(xì)
|
Ac-Tyr-Val-Lys(biotinyl)-Asp-2,6-dimethylbenzoyloxymethylketone |
|
154719-25-2 |
詳細(xì)
|
Peptide YY (human) |
|
118997-30-1 |
詳細(xì)
|
H-Phe-Gly-Phe-Gly-OH |
|
59005-83-3 |
詳細(xì)
|
Indolicidin |
|
140896-21-5 |
詳細(xì)
|
H-Val-Gly-Gly-OH |
|
21835-35-8 |
詳細(xì)
|
H-Glu(Gly-Gly-OH)-OH |
|
13640-39-6 |
詳細(xì)
|
p-Tolylboronic acid |
4-甲基苯硼酸 |
5720-05-8 |
詳細(xì)
|
Lutetium(III) bromide hydrate |
镥(III)溴化水合物 |
29843-94-5 |
詳細(xì)
|
ACTH (11-24) |
|
|
詳細(xì)
|
Sodium hexafluoroarsenate(V) |
六氟砷酸鈉 |
12005-86-6 |
詳細(xì)
|
Dnp-Arg-Asn-Ala-Thr-Ala-Val-NH2 |
|
153919-61-0 |
詳細(xì)
|
6-bromo-5-hydroxyuracil |
|
|
詳細(xì)
|
TYROSINE-TYROSINE |
酪氨酰-L-酪氨酸 |
|
詳細(xì)
|
Boc-Val-Gly-Arg-AMC |
|
|
詳細(xì)
|
ACTH (1-39) (human) |
|
12279-41-3 |
詳細(xì)
|
Biotinyl-Somatostatin-14 |
|
145251-83-8 |
詳細(xì)
|
Trioxo(triphenylsilyloxy)rhenium(VII) |
|
60624-60-4 |
詳細(xì)
|
3-(5-fluoroindol-3-yl)propionic acid |
|
7394-78-7 |
詳細(xì)
|
H-Tyr-Glu-Glu-Trp-OH |
|
|
詳細(xì)
|
2,4,6-Triphenylborazine |
|
976-28-3 |
詳細(xì)
|
N-benzyl-N-(2-chloro-3-pyridinyl)amine |
|
142670-87-9 |
詳細(xì)
|
1-(5-Nitro-2-pyridinyl)-4-piperidinol |
|
353258-16-9 |
詳細(xì)
|
Pyrazole(Z)2 |
N,N'-雙(芐氧羰基)-1H-吡唑-1-甲脒 |
152120-55-3 |
詳細(xì)
|
Trioctylphosphine oxide Cytec quality, >=90% (GC) |
三正辛基氧膦 |
78-50-2 |
詳細(xì)
|
Fmoc-Arg(Me)(Pbf)-OH |
|
1135616-49-7 |
詳細(xì)
|
2-Hydroxy-4-methoxybenzoic acid hydrazide |
|
41697-08-9 |
詳細(xì)
|
Fmoc-Asp(OtBu)-OPfp |
|
86061-01-0 |
詳細(xì)
|
4-(4′-Fluorobenzyloxy)phenylboronic acid |
4-(4'-氟芐氧基)苯基硼酸 |
871125-82-5 |
詳細(xì)
|
Dichloro[rac-ethylenebis(indenyl)]zirconium(IV) |
乙烯基雙茚基二氯化鋯 |
100080-82-8 |
詳細(xì)
|
4-hydroxymethylpyridine-N-oxide |
|
22346-75-4 |
詳細(xì)
|
trans-3-(Cyclopentyl)-1-propenylboronic acid pinacol ester |
反式-3-環(huán)戊基-1-丙烯基硼酸頻那醇酯 |
1073354-57-0 |
詳細(xì)
|
R-3-Amino-4-(1-naphthyl)butyric acid |
R-3-氨基-4-(1-萘基)丁酸 |
269398-88-1 |
詳細(xì)
|
pyrimidin-4(3H)-one |
|
3273-54-9 |
詳細(xì)
|
1H-indole-3-carboxylic acid chloride |
|
59496-25-2 |
詳細(xì)
|
Fmoc-D-Hyp(tBu)-OH |
|
464193-92-8 |
詳細(xì)
|
3-isopropyloxindole |
|
4679-87-2 |
詳細(xì)
|
rac-4-phenyl-2-pyridin-3-yl-but-3-yn-2-ol |
|
55690-03-4 |
詳細(xì)
|
N-(4-chloro-6-methyl-pyrimidin-2-yl)-acetamide |
|
89694-98-4 |
詳細(xì)
|
4-bromo-1-(pyridine-3-ylsulfonyl)-1H-indole |
|
1001394-86-0 |
詳細(xì)
|
2-Cyanophenylzinc bromide solution 0.5M in THF |
2-氰基苯基溴化鋅 |
131379-17-4 |
詳細(xì)
|
|
二氯三乙醚 |
112-26-5 |
詳細(xì)
|
Nociceptin |
|
170713-75-4 |
詳細(xì)
|
Suc-Val-Pro-Phe-SBzl |
|
95192-51-1 |
詳細(xì)
|
Dolastatin 15 |
|
123884-00-4 |
詳細(xì)
|
Neuropeptide Y (22-36) |
|
119019-65-7 |
詳細(xì)
|
H-Leu-Ser-4-nitro-Phe-Nle-Ala-Leu-OH |
|
|
詳細(xì)
|
Bismuth(V) fluoride |
|
7787-62-4 |
詳細(xì)
|
1,3-Bis[(phenylseleno)methyl]benzene 97% |
|
239448-30-7 |
詳細(xì)
|
H-Tyr-Gly-NH2 |
|
99940-62-2 |
詳細(xì)
|
3,4-Dichlorophenylboronic acid |
3,4-二氯苯硼酸 |
151169-75-4 |
詳細(xì)
|
3-Nitrophthalamide |
4、3-硝基鄰苯二甲酰胺 |
96385-50-1 |
詳細(xì)
|
5-Isoquinolineboronic acid |
5-異喹啉硼酸 |
371766-08-4 |
詳細(xì)
|
3,5-Dichlorophenylzinc iodide solution 0.5M in THF |
3,5-二氯苯基碘化鋅 |
312692-86-7 |
詳細(xì)
|
2-p-tolylthiazolo<5,4-b>pyridine |
|
109202-20-2 |
詳細(xì)
|
Yttrium(III) butoxide solution 0.5 in toluene |
|
111941-71-0 |
詳細(xì)
|
Calcitonin (eel) |
|
57014-02-5 |
詳細(xì)
|
(D-Phe2)-VIP (human, bovine, porcine, rat) |
|
104051-15-2 |
詳細(xì)
|
Neuropeptide W-23 (rat) |
|
383415-89-2 |
詳細(xì)
|
4-(2-Propynylcarbamoyl)phenylboronic acid pinacol ester |
4-(2-丙基氨基甲?;?苯基硼酸頻那醇酯 |
|
詳細(xì)
|
Z-Gly-Pro-4MβNA |
|
201983-16-6 |
詳細(xì)
|
Tetramethyl(n-propyl)cyclopentadiene |
四甲基(正丙基)環(huán)戊二烯 |
64417-12-5 |
詳細(xì)
|
Pyr-Phe-Gly-NH2 |
|
|
詳細(xì)
|
Z-Ala-Pro-Gly-OH |
|
23458-25-5 |
詳細(xì)
|
Suc-Ala-Ala-Val-AMC |
|
128972-90-7 |
詳細(xì)
|
2-[Bis(2,4-di-tert-butyl-phenoxy)phosphinooxy]-3,5-di(tert-butyl)phenyl-palladium(II) chloride dimer |
|
217189-40-7 |
詳細(xì)
|
4-Dibenzothienylboronic acid |
二苯并噻吩-4-硼酸 |
108847-20-7 |
詳細(xì)
|
H-Lys(2-chloro-Z)-OBzl HCl |
|
201008-12-0 |
詳細(xì)
|
1-diethylcarbamoyl-3-formylindole |
|
105949-40-4 |
詳細(xì)
|
N-(2-chloro-3-pyridinyl)-4-chlorophenylamide |
|
91813-33-1 |
詳細(xì)
|
3-(2-imidazolin-2-ylthio)-indole-2-carboxylic acid hydriodide |
|
55107-63-6 |
詳細(xì)
|
Boc-S-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid |
Boc-S-3-氨基-4-(4-三氟甲基苯基)丁酸 |
270065-80-0 |
詳細(xì)
|
2,6-Dichloropyridine N-Oxide |
2,6-二氯代吡啶-N-氧化物 |
2587-00-0 |
詳細(xì)
|
Fmoc-D-Arg(Pmc)-OPfp |
|
200188-07-4 |
詳細(xì)
|
Boc-Glu-OFm |
|
133906-29-3 |
詳細(xì)
|
Pyrido[2,3-b]pyrazin-7-ylboronic acid pinacol ester |
吡啶[2,3-b]吡嗪-7-基硼酸頻那醇酯 |
1210047-44-1 |
詳細(xì)
|
tert-butyl 3-methyl-1H-indole-1-carboxylate |
|
89378-43-8 |
詳細(xì)
|
N-Fmoc-D-3-Amino-3-(3-nitrophenyl)propanoic acid |
N-Fmoc-D-3-氨基-3-(3-硝基苯基)丙酸 |
374791-04-5 |
詳細(xì)
|
Z-Ile-Ile-OH |
|
42538-01-2 |
詳細(xì)
|
Boc-D-Asp(OtBu)-OH DCHA |
|
200334-95-8 |
詳細(xì)
|
2-(4-fluorophenyl)-4-pyridinamine |
|
886366-09-2 |
詳細(xì)
|
Cyclohexylzinc bromide solution 0.5M in THF |
環(huán)己基溴化鋅 |
7565-57-3 |
詳細(xì)
|
N-(Benzotriazol-1-yl-p-tolyl-methyl)-nicotinamide |
|
182491-51-6 |
詳細(xì)
|
5-(4-chlorobutoxy)-1H-indole |
|
873696-54-9 |
詳細(xì)
|
N-(5-chloropyridin-2-yl)-N'-phenylurea |
|
10461-91-3 |
詳細(xì)
|
Hippuryl-Lys-OH |
|
740-63-6 |
詳細(xì)
|
Pyr-Pro-Val-pNA |
|
83329-36-6 |
詳細(xì)
|
HIV-1 tat Protein (1-9) |
|
200203-20-9 |
詳細(xì)
|
H-Lys-Glu-Thr-Tyr-Ser-Lys-OH |
|
|
詳細(xì)
|
Galanin (human) |
|
119418-04-1 |
詳細(xì)
|
PAR-4 (1-6) (human) |
|
225779-44-2 |
詳細(xì)
|
Diphenyl(trimethylsilyl)phosphine |
二苯基(三甲基甲硅烷基)膦 |
17154-34-6 |
詳細(xì)
|